博九娱乐网

Castle Biosciences (Nasdaq: CSTL) is a commercial-stage dermatologic cancer company focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The Company currently offers tests for patients with cutaneous melanoma (DecisionDx庐-Melanoma, DecisionDx庐-CMSeq; www.SkinMelanoma.com), cutaneous squamous…More cell carcinoma (DecisionDx庐-SCC, www.mySCCskincancer.com) and uveal melanoma (DecisionDx庐-UM, DecisionDx庐-PRAME and DecisionDx庐-UMSeq; www.MyUvealMelanoma.com). Castle also has products in development for other underserved cancers, the most advanced of which is focused on patients who have a difficult-to-diagnose pigmented lesion. Castle Biosciences is based in Friendswood, Texas (Houston), and has laboratory operations in Phoenix, Arizona.